Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing management

Abstract Background Pediatric patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) are at an increased risk of arterial and venous thromboembolism (AVTE). Although the exact mechanisms underlying AVTE remain unclear, eosinophils play a pivotal role in AVTE. Main body Current guidelines...

Full description

Saved in:
Bibliographic Details
Main Authors: Batuhan Küçükali, Merve Yazol, Çisem Yıldız, Büşra Acun, Nuran Belder, Nihal Karaçayır, Merve Kutlar, Pelin Esmeray Şenol, Zühre Kaya, Deniz Gezgin Yıldırım, Sevcan A. Bakkaloğlu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Pediatric Rheumatology Online Journal
Subjects:
Online Access:https://doi.org/10.1186/s12969-024-01054-3
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559822003077120
author Batuhan Küçükali
Merve Yazol
Çisem Yıldız
Büşra Acun
Nuran Belder
Nihal Karaçayır
Merve Kutlar
Pelin Esmeray Şenol
Zühre Kaya
Deniz Gezgin Yıldırım
Sevcan A. Bakkaloğlu
author_facet Batuhan Küçükali
Merve Yazol
Çisem Yıldız
Büşra Acun
Nuran Belder
Nihal Karaçayır
Merve Kutlar
Pelin Esmeray Şenol
Zühre Kaya
Deniz Gezgin Yıldırım
Sevcan A. Bakkaloğlu
author_sort Batuhan Küçükali
collection DOAJ
description Abstract Background Pediatric patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) are at an increased risk of arterial and venous thromboembolism (AVTE). Although the exact mechanisms underlying AVTE remain unclear, eosinophils play a pivotal role in AVTE. Main body Current guidelines lack evidence-based recommendations, particularly concerning anticoagulant and antiplatelet treatments for this condition. Herein, we document a pediatric EGPA patient with deep venous thrombosis presenting with massive pulmonary thromboembolism during a relapse, treated with immunosuppressive and anticoagulant therapy to raise awareness among clinicians. Additionally, we performed a literature review to highlight various aspects of pediatric AVTE. Moreover, we evaluated the management strategies employed for the patients identified in the literature review and summarized the current practice guidelines regarding pediatric EGPA patients with AVTE to provide recommendations to clinicians on the management of this challenging complication. Conclusions Most AVTE events occur during periods of high disease activity. Notably, EGPA patients with VTE often present with thrombocytopenia due to consumption, a finding not typically expected during disease exacerbation. Venous thrombosis generally requires both anticoagulation and immunosuppressive treatment. Although our review indicates a favorable prognosis for AVTE, the small number of reported cases prevents us from drawing definitive conclusions. Future studies should explore the efficacy of mepolizumab and other eosinophil-targeted therapies for AVTE, in addition to investigating the roles of anticoagulation and antiplatelet treatments.
format Article
id doaj-art-85e02213557e4fc0abcc7c2be41d5679
institution Kabale University
issn 1546-0096
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Pediatric Rheumatology Online Journal
spelling doaj-art-85e02213557e4fc0abcc7c2be41d56792025-01-05T12:11:16ZengBMCPediatric Rheumatology Online Journal1546-00962025-01-0123111010.1186/s12969-024-01054-3Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing managementBatuhan Küçükali0Merve Yazol1Çisem Yıldız2Büşra Acun3Nuran Belder4Nihal Karaçayır5Merve Kutlar6Pelin Esmeray Şenol7Zühre Kaya8Deniz Gezgin Yıldırım9Sevcan A. Bakkaloğlu10Department of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Radiology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Hematology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityDepartment of Pediatric Rheumatology, Faculty of Medicine, Gazi UniversityAbstract Background Pediatric patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) are at an increased risk of arterial and venous thromboembolism (AVTE). Although the exact mechanisms underlying AVTE remain unclear, eosinophils play a pivotal role in AVTE. Main body Current guidelines lack evidence-based recommendations, particularly concerning anticoagulant and antiplatelet treatments for this condition. Herein, we document a pediatric EGPA patient with deep venous thrombosis presenting with massive pulmonary thromboembolism during a relapse, treated with immunosuppressive and anticoagulant therapy to raise awareness among clinicians. Additionally, we performed a literature review to highlight various aspects of pediatric AVTE. Moreover, we evaluated the management strategies employed for the patients identified in the literature review and summarized the current practice guidelines regarding pediatric EGPA patients with AVTE to provide recommendations to clinicians on the management of this challenging complication. Conclusions Most AVTE events occur during periods of high disease activity. Notably, EGPA patients with VTE often present with thrombocytopenia due to consumption, a finding not typically expected during disease exacerbation. Venous thrombosis generally requires both anticoagulation and immunosuppressive treatment. Although our review indicates a favorable prognosis for AVTE, the small number of reported cases prevents us from drawing definitive conclusions. Future studies should explore the efficacy of mepolizumab and other eosinophil-targeted therapies for AVTE, in addition to investigating the roles of anticoagulation and antiplatelet treatments.https://doi.org/10.1186/s12969-024-01054-3EGPAThromboembolismPulmonary embolismChurg-Strauss SyndromeEosinophilic Granulomatosis with Polyangiitis
spellingShingle Batuhan Küçükali
Merve Yazol
Çisem Yıldız
Büşra Acun
Nuran Belder
Nihal Karaçayır
Merve Kutlar
Pelin Esmeray Şenol
Zühre Kaya
Deniz Gezgin Yıldırım
Sevcan A. Bakkaloğlu
Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing management
Pediatric Rheumatology Online Journal
EGPA
Thromboembolism
Pulmonary embolism
Churg-Strauss Syndrome
Eosinophilic Granulomatosis with Polyangiitis
title Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing management
title_full Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing management
title_fullStr Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing management
title_full_unstemmed Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing management
title_short Massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis: a case-based review emphasizing management
title_sort massive pulmonary thromboembolism in a pediatric patient with eosinophilic granulomatosis with polyangiitis a case based review emphasizing management
topic EGPA
Thromboembolism
Pulmonary embolism
Churg-Strauss Syndrome
Eosinophilic Granulomatosis with Polyangiitis
url https://doi.org/10.1186/s12969-024-01054-3
work_keys_str_mv AT batuhankucukali massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT merveyazol massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT cisemyıldız massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT busraacun massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT nuranbelder massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT nihalkaracayır massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT mervekutlar massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT pelinesmeraysenol massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT zuhrekaya massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT denizgezginyıldırım massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement
AT sevcanabakkaloglu massivepulmonarythromboembolisminapediatricpatientwitheosinophilicgranulomatosiswithpolyangiitisacasebasedreviewemphasizingmanagement